Phase I Clinical Trial with a Novel Altered Peptide Ligand Derived from Human Heat-Shock Protein 60 for Treatment of Rheumatoid Arthritis: Safety, Pharmacokinetics and Preliminary Therapeutic Effects
2016 ◽
Vol 21
(4)
◽
pp. 735-744
◽
2013 ◽
Vol 17
(4)
◽
pp. 1075-1083
◽
1996 ◽
Vol 39
(11)
◽
pp. 1826-1832
◽
2002 ◽
Vol 106
(2)
◽
pp. 196-201
◽
Keyword(s):